Related by context. All words. (Click for frequent words.) 74 pharmacological approaches 74 pharmacological interventions 73 pharmacological treatments 70 nonpharmacologic 69 pharmacologic treatments 69 pharmacological therapy 69 dietary interventions 67 pharmacotherapies 67 neurocognitive deficits 67 testosterone supplementation 67 pharmacological intervention 66 Cognitive behavioral 66 nondrug treatments 66 aromatase inhibitors AIs 66 oral anticoagulation 66 antithrombotic therapy 66 antiplatelet therapies 66 dyslipidemias 66 antioxidant supplementation 66 pharmacologic approaches 66 nonpharmacological 66 somatostatin analogs 66 antidepressive 65 therapeutic regimens 65 hypochondriasis 65 probiotic supplementation 65 DHEA supplementation 65 dietary modification 65 postoperative atrial fibrillation 65 pharmacotherapeutic 65 agomelatine 65 Heavy snorers 65 neurocognitive function 64 immunosuppressive therapies 64 hypertension diabetes mellitus 64 pharmacologic therapies 64 inotropes 64 pathophysiological processes 64 poststroke depression 64 antidepressant efficacy 64 thromboembolic disease 64 non pharmacological interventions 64 Calorie restriction 64 thiopurine 64 Atypical antipsychotics 64 atypical neuroleptics 64 venous thromboembolic disease 64 intranasal corticosteroids 64 treating neuropathic pain 64 Genetic predisposition 64 somatoform disorders 64 nonalcoholic steatohepatitis NASH 63 postoperative AF 63 riociguat 63 AChE inhibitors 63 antipsychotic induced 63 malabsorptive 63 bone metabolism 63 neuropsychological impairments 63 therapeutic armamentarium 63 psychotherapies 63 oral NSAIDs 63 oncological outcomes 63 pain syndromes 63 antiplatelet medications 63 immunosuppressive regimens 63 comorbid disorders 63 psychopharmacologic 63 Lofexidine 63 endocrine therapies 63 compensatory mechanisms 63 oral anticoagulant therapy 63 inhaled bronchodilators 63 psychotherapeutic interventions 63 neuroleptics 62 analgesic medications 62 dietary antioxidants 62 comorbid depression 62 cartilage degeneration 62 neurodevelopmental outcome 62 biphosphonates 62 overactive bladder symptoms 62 dysfunctional voiding 62 Histalean TM 62 colorectal carcinogenesis 62 primary hyperparathyroidism 62 noscapine 62 growth hormone secretion 62 pharmacological 62 nutrient supplementation 62 cardiotoxic 62 diagnosing ADHD 62 β blockers 62 fibrotic disease 62 hormone therapy HT 62 pramlintide metreleptin combination 62 rheumatic disorders 62 neuroleptic drugs 62 pharmacologic 62 chromium supplementation 62 Magnesium deficiency 62 diagnostic modality 62 lung cancer chemoprevention 62 pharmacologic intervention 62 postmenopausal hormone 62 metaanalysis 62 sacral nerve stimulation 62 etiologic factors 62 Cognitive therapy 62 biologic plausibility 62 postoperative morbidity 62 perioperative morbidity 62 neurobehavioural 61 lipid lowering agents 61 topical NSAIDs 61 HIV lipodystrophy 61 prostate cancer CaP 61 RISPERDAL ® 61 hematopoietic cancers 61 postmenopausal estrogen 61 NMDA antagonists 61 pulmonary toxicity 61 statins cholesterol lowering 61 intracranial hypertension 61 TNF alpha antagonist 61 GnRH agonists 61 urothelial cancer 61 pathophysiological mechanisms 61 metabonomics 61 COMT inhibitors 61 potentially modifiable 61 comorbid psychiatric 61 interventional therapies 61 noninfectious uveitis 61 deferiprone 61 lipid lowering therapies 61 cognitive behavioral therapies 61 prostaglandin analogues 61 T1DM 61 psychopharmacological 61 Spinal manipulation 61 antiangiogenic agents 61 kidney urologic 61 chemopreventive agents 61 neuropsychiatric diseases 61 neuroprotective agent 61 stratifying patients 61 cranial irradiation 61 H. pylori eradication 61 postoperative pulmonary 61 cardiometabolic disorders 61 antihypertensive therapy 61 mitochondrial toxicity 61 systemic corticosteroid 61 dopaminergic therapy 61 opiate analgesics 61 thromboprophylaxis 61 parkinsonian symptoms 61 glitazones 61 chronic periodontitis 61 anticonvulsant medications 61 direct thrombin inhibitors 61 psychiatric comorbidity 61 intracranial stenosis 61 neurosensory 61 underlying pathophysiology 61 CYP#A# inhibitors 61 biopsychosocial 61 skeletal metastases 61 LLLT 61 Therapeutic hypothermia 61 intravenous cyclophosphamide 61 coronary revascularization procedures 61 pyridostigmine 61 antiarrhythmic 61 antireflux surgery 61 leukotriene receptor antagonists 61 androgen ablation 61 antiemetics 61 opioid misuse 61 SERMs 61 trastuzumab Herceptin ® 61 Topical corticosteroids 61 nabilone 61 benign prostatic hypertrophy BPH 61 diabetic kidney 60 antidepressants SSRIs 60 psychosocial functioning 60 neurodevelopmental outcomes 60 incidentalomas 60 neuroinflammatory diseases 60 ß blockers 60 nonalcoholic steatohepatitis 60 lomitapide 60 antiepileptics 60 FSAD 60 decompensated cirrhosis 60 CB1 antagonists 60 cardiovascular disease hypertension 60 Zevalin consolidation 60 prostate carcinogenesis 60 glucocorticoid therapy 60 neuro cognitive 60 guideline concordant 60 immunomodulatory agents 60 chronic prostatitis chronic 60 Chronic pancreatitis 60 developmental neurotoxicity 60 intensive lipid lowering 60 acamprosate 60 metabolic dysfunction 60 hepatic encephalopathy HE 60 iron chelators 60 anticholinergic agents 60 ICS LABA combination 60 immunomodulation 60 systemic immunosuppressive drugs 60 anti angiogenic drugs 60 Cognitive impairment 60 neovascular diseases 60 sotalol 60 invasive candidiasis 60 secondary amenorrhea 60 cognitive enhancers 60 depressive illnesses 60 impaired cognition 60 knee osteoarthritis OA 60 uric acid lowering 60 ursodeoxycholic acid 60 psychostimulants 60 immune modulating 60 Statin therapy 60 newer atypical antipsychotics 60 antidiabetic therapy 60 therapies 60 antidiabetic medications 60 CYT# potent vascular disrupting 60 PNH patients 60 INVEGA ® 60 antidiabetic drugs 60 atypical antipsychotic medications 60 noncancer pain 60 antimicrobial prophylaxis 60 maladaptive behaviors 60 anti angiogenic agents 60 infantile colic 60 thetreatment 60 antiarrhythmic medications 60 androgen deficiency 60 thyroid deficiency 60 Inhaled corticosteroids 60 oral naltrexone 60 dyslipidaemia 60 empiric therapy 60 linear pharmacokinetics 60 imatinib resistance 60 non selective NSAIDs 60 PDE4 inhibitors 60 Caloric restriction 60 adjuvant therapies 60 mixed hyperlipidemia 60 antiangiogenic therapy 60 Psychosocial interventions 60 canakinumab 60 maximally tolerated lipid lowering 60 Temporal lobe epilepsy 60 Prostatitis 60 COX inhibitors 60 GI motility disorders 60 rEV# 60 therapeutic modalities 60 lumbar disk herniation 60 SIADH 60 CAM modalities 60 proliferative diabetic retinopathy 60 antiarrhythmic drugs 60 chronic myocardial ischemia 60 interpersonal psychotherapy 60 post surgical adhesions 60 Adjuvant chemotherapy 60 insulin sensitizing drug 60 Bisphosphonate 60 antidiabetic agents 60 hepatic fibrosis 60 PPAR gamma agonists 60 neuropsychological impairment 60 antiarrhythmic drug 60 embolic stroke 60 insulin analogs 60 cetilistat 60 colorectal adenoma 60 biochemical abnormalities 60 hormonal abnormalities 60 VTE prophylaxis 60 thyroid dysfunction 60 allogeneic HSCT 60 cardio metabolic 60 resynchronization therapy 60 pharmacologic therapy 60 aromatase inhibitor therapy 60 dosing frequency 60 AGHD 60 inhaled glucocorticoids 60 secondary hyperparathyroidism 60 aldosterone antagonist 60 immunosuppressive regimen 60 ALI ARDS 60 thrombo embolic 60 primary aldosteronism 60 lipid parameters 60 pathophysiologic 60 depression suicidal ideation 59 Cognitive behavioral therapy 59 rheumatic diseases 59 PPAR agonist 59 levodopa induced 59 aripiprazole Abilify 59 psychosocial variables 59 abnormal lipids 59 Helicobacter pylori eradication 59 EBV infection 59 davalintide 59 EEG abnormalities 59 anti epileptics 59 behavioral interventions 59 mTOR inhibitors 59 TMP SMX 59 neuro degenerative diseases 59 LAGB 59 varenicline Chantix 59 neurocognitive functioning 59 antiandrogens 59 recurrent miscarriage 59 atrial tachyarrhythmias 59 comorbid psychiatric disorders 59 Liver transplantation 59 CYP#D# inhibitor 59 severe hypoglycaemia 59 comorbid conditions 59 antiplatelets 59 somatic complaints 59 diabetic gastroparesis 59 postoperative radiotherapy 59 corticosteroid injections 59 radiographic findings 59 methodologic 59 hematopoietic malignancies 59 psychiatric comorbidities 59 BoNTA 59 rheumatoid arthritis osteoarthritis ankylosing 59 H2 antagonists 59 Severe Primary IGFD 59 neuropsychological functioning 59 curative therapies 59 aspirin NSAIDs 59 acetylcholinesterase inhibitors 59 vasomotor symptoms 59 therapy CBT 59 SRBD 59 PYY nasal spray 59 etiological 59 haematologic 59 TNF alpha inhibitor 59 hyperuricaemia 59 pulmonary hypertension PH 59 dopamine D2 receptors 59 postoperative mortality 59 metformin Glucophage 59 antiandrogen 59 fragility fractures 59 lipodystrophy syndrome 59 neurotrophic 59 antiresorptive 59 hepatocellular 59 atherogenesis 59 physiologic mechanisms 59 fluoxetine Prozac 59 TNF antagonist 59 Pagoclone 59 paroxetine Paxil 59 fibrate drugs 59 urolithiasis 59 heritable diseases 59 NNT = 59 neuropsychiatric symptoms 59 velafermin 59 Calcium intake 59 LHRH agonist 59 neuro psychiatric disorders 59 macrolide antibiotics 59 atherosclerotic renal artery stenosis 59 pharmacokinetic interactions 59 oncologic outcomes 59 carotid angioplasty 59 prognostic indicators 59 CLBP 59 gemifloxacin 59 cholinesterase inhibitors 59 vaginal hysterectomy 59 gynecologic procedures 59 aetiology 59 IBS sufferers 59 chronic neuropathic pain 59 statin medications 59 cognitive enhancer 59 antithrombotic agents 59 transdermal estrogen 59 juvenile idiopathic arthritis JIA 59 refractory angina 59 diabetic polyneuropathy 59 loop diuretics 59 subclinical disease 59 meta analytic 59 #F FDG PET 59 anticoagulant warfarin 59 chemopreventive agent 59 adjunctive therapies 59 hawthorn extract 59 guanfacine extended release 59 pharmacologic interventions 59 IV bisphosphonates 59 Alessandro Riva 59 immunopathology 59 opioid dependent 59 pharmacodynamic parameters 59 megestrol acetate 59 dyslipidemic patients 59 steroid inhalers 59 cardioprotection 59 Nalmefene 59 serotonin reuptake inhibitors 59 Radical prostatectomy 59 postmenopausal hormone replacement 59 efficacious therapies 59 androgen deprivation 59 clomipramine 59 insulin resistance syndrome 59 curative therapy 59 impair cognitive 59 LUTS 59 intravenous bisphosphonates 59 Interferon beta 59 pathophysiological 59 adrenal function 58 Meta analyzes 58 Soy isoflavones 58 Topical treatments 58 degenerative neurological diseases 58 LDL lowering 58 radiographic outcomes 58 lethal arrhythmias 58 C1 INH deficiency 58 chemoprevention trials 58 Clot busting 58 Subgroup analyzes 58 NSAID induced 58 tumor histology 58 potassium sparing diuretics 58 allergic rhinitis hay fever 58 diagnosing autism 58 homoeopathic remedies 58 allergen avoidance 58 AGILECT R 58 epidural steroid injection 58 antimetabolites 58 pharmacogenetic tests 58 Achilles tendon ruptures 58 Muscle relaxants 58 Valdoxan 58 menopausal symptom 58 Perforomist ™ Inhalation Solution 58 cardiac repolarization 58 rhIGF-I/rhIGFBP-3 58 Surgical resection 58 symptomatic paroxysmal AF 58 DVT PE 58 carotid bruit 58 infliximab Remicade 58 menstrual dysfunction 58 ICD therapy 58 carotid IMT 58 Adverse effects 58 hormonal deficiencies 58 antithrombotic agent 58 hippocampal neurogenesis 58 chronic LBP 58 reflux symptoms 58 autonomic dysfunction 58 cardiovascular disease osteoporosis 58 cerebral vasospasm 58 pouchitis 58 HIV HCV coinfected 58 gastrointestinal GI motility disorders 58 inotropic agents 58 tolerability profiles 58 antiplatelet drugs 58 metabolic disturbances 58 DACH platinum 58 antibiotic regimens 58 bacterial prostatitis 58 subclinical inflammation 58 neuroleptic 58 percutaneous vertebroplasty 58 acetabular dysplasia 58 Pseudomonas aeruginosa infections 58 neonatal circumcision 58 uncontrolled epilepsy 58 creatine supplementation 58 anticancer treatments 58 periodontal tissues 58 impair fertility 58 insulin sensitizing 58 GH deficiency 58 Calcium vitamin D 58 periprocedural MI 58 hoFH patients 58 myocardial ischaemia 58 ganaxolone 58 Arthrizyme ™ 58 aldosterone antagonists 58 systemic fungal infections 58 clevidipine 58 Venous thromboembolism 58 AOD# [002] 58 chronic thromboembolic pulmonary 58 digestive disturbances 58 paricalcitol 58 thrombotic diseases 58 OSAHS 58 nonpharmacological treatments 58 alcoholic fatty liver 58 Myerburg 58 stimulant ADHD 58 ocular disorders 58 comorbid illnesses 58 extrapyramidal symptoms 58 Genetic variants 58 oral anticoagulants 58 fragility fracture 58 fermentable carbohydrates 58 acute GVHD 58 postoperative delirium 58 carotid atherosclerosis 58 Surgical excision 58 glial tumors 58 Cognitive Behavioural Therapy CBT 58 Cardiotoxicity 58 haematological cancers 58 droperidol 58 pentoxifylline 58 idiopathic intracranial hypertension 58 colon carcinogenesis 58 underdiagnosis 58 membranous nephropathy 58 opiate dependency 58 hormonal therapies 58 antithrombotics 58 PDE# inhibitors 58 chronic prostatitis 58 antithrombotic 58 airway narrowing 58 opioid antagonists 58 vitamin D inadequacy 58 intracerebral haemorrhage 58 antiepileptic drugs AEDs 58 photodamaged skin 58 nutritional supplementation 58 apneic episodes 58 serum lipid levels 58 interferon ribavirin 58 primary spontaneous pneumothorax 58 eprotirome 58 sargramostim 58 obese adolescents 58 Alzheimer Disease AD 58 autoantibody levels 58 neurocognitive impairment 58 neuroregenerative 58 CTEPH 58 Cymbalta duloxetine HCl 58 Inflammatory diseases 58 vascular endothelial dysfunction 58 prokinetic 58 ALISTA 58 Antioxidant supplements 58 valve implantation 58 HeFH 58 sonographic diagnosis 58 perinatal outcomes 58 eluding stents 58 CPAP adherence 58 protein misfolding diseases 58 nonsurgical treatments 58 Singh Manoux 58 vascular dysfunction 58 osteoarthritic 58 vidofludimus 58 hepatotoxic 58 CP CPPS 58 androgen therapy 58 functional gastrointestinal disorders 58 rufinamide 58 symptomatic hyponatremia 58 Wischik 58 MBCT 58 blood clot dissolving 58 therapeutic interventions 58 lymphoma subtypes 58 IOP lowering 58 nonvertebral fracture 58 nociceptive pain 58 Effexor venlafaxine 58 vitamin supplementation 58 renoprotective 58 vascular abnormalities 58 thrombotic complications 58 renal toxicity 58 neurobiological mechanisms 58 antitumor efficacy 58 cystinosis patients 58 polyp recurrence 58 bronchopulmonary dysplasia BPD 58 Wernicke Korsakoff syndrome 58 cardiotoxic effects 58 vitamin D analogs 58 postoperative infections 58 aerosolized KL4 surfactant 58 Therapeutic antibodies 58 mechanistic studies 58 CaPre TM 58 sirtuin activators 58 G6PD deficiency 58 biopsychosocial model 58 androgen depletion therapy 58 Tranexamic acid 58 Triptans 58 corticosteroid induced 58 selenium supplementation 58 improves glycemic 58 cytoreductive nephrectomy 58 surgical interventions 58 vasodilators 58 phosphate binders 58 Neurological disorders 58 myocardial reperfusion 58 mycophenolate mofetil MMF 58 neuro degenerative disorders 58 KRAS status 58 chronic renal disease 58 Acamprosate 58 adipose derived stem cell 58 unmeasured confounders 58 neovascularisation 58 Uncontrolled hypertension 58 Rheos System 58 Insulin detemir 58 HNSCC 58 corticosteroid therapy 58 non ulcer dyspepsia 58 Herbal remedies 58 lipid abnormalities 58 primidone 58 recurrent tonsillitis 58 hypocalcaemia 58 bilateral oophorectomy 58 nongenetic 58 Glucocorticoids 58 Comparative effectiveness 58 arterial calcification 58 inotropic 58 lupus scleroderma 58 erlotinib Tarceva 58 rheumatologic 58 Teriparatide 58 shorter telomere length 58 Aggrastat ® tirofiban hydrochloride 58 antiplatelet medication 58 prophylactic preventive 58 HCV protease inhibitors 58 renal scarring 58 STEP BD 58 motor neuron degeneration 58 androgen depletion 58 CVD cardiovascular disease 58 adenoidectomy 58 affective disorders 58 erythropoietic 57 prenatal exposures 57 stem cell transplantations 57 Tibolone 57 nosology 57 acute mania 57 calcineurin inhibitors 57 doxorubicin HCl 57 memantine Namenda 57 periodontal infections 57 perioperative complications 57 albumin excretion 57 metabolic dysfunctions 57 pathophysiologic mechanisms 57 atypical femur fractures 57 unmeasured factors 57 PROCHYMAL 57 pharmacotherapy 57 irritability insomnia 57 aetiological 57 Aprotinin 57 ovarian hormones 57 upper gastrointestinal bleeding 57 coronary stenting 57 torsade de pointes 57 investigational therapies 57 lipid lowering therapy 57 atrial arrhythmias 57 oral hypoglycemic agent 57 circadian rhythm disorders 57 Oral corticosteroids 57 antitumour 57 macrovascular events 57 MAGE A3 ASCI 57 Anti psychotics 57 plasminogen activators 57 obstetric complications 57 Carotid endarterectomy 57 H2 receptor antagonists 57 late onset hypogonadism 57 mGluR5 inhibition 57 adjunctively 57 opiod 57 lowering blood glucose 57 factor TNF 57 Combination therapy 57 pramipexole Mirapex 57 immunotherapeutic approaches 57 MGN# 57 multimodality therapy 57 therapeutical 57 cyclic HMB 57 osteoarthritis sufferers 57 Myriad Flurizan 57 thoracoscopic lobectomy 57 Dr. Sharonne Hayes 57 LNP formulations 57 pathogenetic mechanisms 57 Interpersonal psychotherapy 57 cardiometabolic risk 57 glucose homeostasis 57 akinetic mutism 57 postoperative ileus 57 antiepileptic medications 57 HMG CoA reductase inhibitors 57 glycosylated hemoglobin levels 57 strontium ranelate 57 atherosclerotic vascular disease 57 topical calcineurin inhibitors 57 endocrinologic 57 Protelos 57 lung fibrosis 57 antianginal 57 tamoxifen raloxifene 57 endometrial hyperplasia 57 pharmacokinetic interaction 57 L dopa 57 inhaled corticosteroid therapy 57 GERD sufferers 57 neurobiological underpinnings 57 Suicidal ideation 57 NUCYNTA R 57 APOE genotype 57 intravesical therapy 57 insulin sensitizing agents 57 NTx ® -# 57 tamoxifen Nolvadex ® 57 muscle dysmorphia 57 abstinent alcoholics 57 psychostimulant 57 oxcarbazepine 57 immunostimulatory effects 57 MediGene focuses 57 Minimally invasive procedures 57 liprotamase 57 Vitamin D supplementation 57 cardiovascular morbidity 57 serum folate concentrations 57 thrombolytic agents 57 neuropsychological assessment 57 constipation predominant irritable bowel 57 hip resurfacing arthroplasty 57 acute respiratory tract infections 57 Pfizer Aricept 57 OAB symptoms 57 caspofungin 57 alendronate Fosamax 57 platelet activation 57 conventional DMARDs 57 photoprotection 57 dual antiplatelet 57 T2DM 57 Androgen deprivation therapy 57 clinicopathological 57 AA Amyloidosis 57 Frontal lobe 57 somatostatin analogues 57 triglyceride lowering 57 nonadherence 57 premenstrual syndrome PMS 57 disc degeneration 57 overt nephropathy 57 euthymic patients 57 Valproic acid 57 metabolic alterations 57 hereditary predisposition 57 geriatric syndromes 57 sJIA 57 neuroinflammation 57 p# activation 57 dermatologic conditions 57 coexisting illnesses 57 Itopride 57 conventional angiography 57 vascular constriction 57 biomedically 57 imexon 57 recombinant erythropoietin 57 medication nonadherence 57 alexithymia 57 adipiplon 57 limb sparing 57 Heavy menstrual bleeding 57 folic acid vitamin B# 57 cardioprotective effects 57 ADME properties 57 colonoscopic 57 glycosylated hemoglobin HbA1c 57 ischemic mitral regurgitation 57 anticancer therapy 57 sulphonylureas 57 systemic hypotension 57 induced hypoglycemia 57 Inhaled insulin 57 hepatic cirrhosis 57 follicular adenoma 57 abnormal Pap smears 57 Tasimelteon 57 antibiotic prophylaxis 57 treating menopausal symptoms 57 impaired insulin secretion 57 behavioral disturbances 57 Corticosteroid injections 57 treatmentof 57 ALK inhibitors 57 voiding dysfunction 57 methodologically rigorous 57 neurologic disorders 57 Sudhir Agrawal D.Phil 57 somatic symptoms 57 hypercholesterolaemia 57 elevated homocysteine 57 tibolone 57 pathologic fractures 57 artery stenosis 57 INVEGA ® SUSTENNA TM 57 endocrine dysfunction 57 nonsteroidal antiinflammatory drugs 57 micafungin 57 Testosterone deficiency 57 hypertonic saline 57 symptomatic fibroids 57 ergogenic aids 57 leukotriene receptor antagonist 57 rituximab Rituxan 57 Erythropoietic therapies may 57 Observational studies 57 acid suppressing 57 immunosuppressive agents 57 NovaBay Aganocide compounds 57 gefitinib Iressa 57 CYP #A# 57 constipation OIC 57 dexanabinol 57 symptomatic benign prostatic 57 fusion enhancers 57 Cholinesterase inhibitors 57 oral talactoferrin 57 mTOR inhibition 57 therapeutic modality 57 Rezular 57 macrovascular disease 57 tibial plateau fractures 57 androgen hormone 57 Mechanical ventilation 57 heparins 57 patients undergoing CABG 57 Mood disorders 57 Thyroid disorders 57 Alpha lipoic acid 57 cytotoxic therapies 57 methotrexate therapy 57 Calcium supplements 57 vitamin B1 deficiency 57 adrenal suppression 57 hepatic insufficiency 57 bony metastases 57 NMES 57 renal fibrosis 57 symptomatic intracranial 57 Eli Lilly Cymbalta 57 chronic musculoskeletal 57 small molecule activators 57 topical retinoids 57 thrombophilia 57 Ginkgo extract 57 Mitomycin C 57 onset diabetes mellitus 57 breast endometrial 57 taribavirin 57 FXIII 57 relapsed ovarian cancer 57 metabolic derangement 57 dexmedetomidine 57 antidiabetic medication 57 recurrent glioblastoma multiforme 57 oral corticosteroid 57 lipid profiles 57 neuropathies 57 pharmacoeconomic 57 acute gout 57 gastrointestinal motility 57 LDL cholesterol lowering 57 biologic DMARDs 57 Squalamine 57 analgesic effects 57 Cachexia 57 HbA1C levels 57 Iron deficiency anemia 57 ventricular remodeling 57 genomic biomarker 57 amisulpride 57 long acting bronchodilator 57 root caries 57 plasma lipid 57 melatonin supplements 57 generalisability 57 opiate dependence 57 PASI scores 57 coronary revascularizations 57 post thrombotic syndrome 57 vertebral subluxation 57 hypercholesterolemia 57 postsurgical pain 57 targeting PCSK9 57 meta analytic review 57 Adjunctive 57 TMS Therapy 57 Zemplar Capsules 57 gabapentin Neurontin 57 empiric treatment 57 pharmacogenetic testing 57 urinary symptoms 57 lesional 57 functional dyspepsia 57 pyrimethamine 57 psychotherapeutic treatments 57 aldosterone hormone 57 tumor subtype 57 topical formulations 57 hepatorenal syndrome 57 selenium intake 57 dermatologic diseases 57 Inhaled nitric oxide 57 aspirin clopidogrel 57 biochemical imbalances 57 untreated OSA 57 osteoporosis osteopenia 57 smoking cessation therapies 57 acute myocardial ischemia 57 intravenous diuretics 57 Vitamin B# deficiency 57 phenelzine 57 SSRI antidepressant 57 multivitamin supplements 57 chiropractic manipulation 57 multitargeted 57 atypical hemolytic uremic syndrome 57 ALSFRS R 57 metabolic parameters 57 neurogenerative diseases 57 tricyclic antidepressant 57 chronic noncancer pain 57 iron supplementation 57 neuronal dysfunction 57 suppressive therapy 57 synaptic function 57 multivitamin supplementation 57 levocetirizine 57 rosuvastatin Crestor 57 catheter ablations 57 cardiometabolic 57 colorectal liver metastases